Literature DB >> 15274033

Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families.

Xiangning Chen1, Cynthia Dunham, Seth Kendler, Xu Wang, F Anthony O'Neill, Dermot Walsh, Kenneth S Kendler.   

Abstract

The regulator of the G-protein signaling 4 (RGS4) gene was shown to have a different expression pattern in schizophrenia patients in a microarray study. A family-based study subsequently implicated the association of this gene with schizophrenia. We replicated the study with our sample from the Irish Study of High Density Schizophrenia Families (ISHDSF). Single marker transmission disequilibrium tests (TDT) for the four core SNPs showed modest association for SNP 18 (using a narrow diagnostic approach with FBAT P = 0.044; with PDT P = 0.0073) and a trend for SNP 4 (with FBAT P = 0.1098; with PDT P = 0.0249). For SNP 1 and 7, alleles overtransmitted to affected subjects were the same as previously reported. Haplotype analyses suggested that haplotype G-G-G for SNP1-4-18, which is the most abundant haplotype (42.3%) in the Irish families, was associated with the disease (narrow diagnosis, FBAT P = 0.0061, PDT P = 0.0498). This was the same haplotype implicated in the original study. While P values were not corrected for multiple testing because of the clear prior hypothesis, these results could be interpreted as supporting evidence for the association between RGS4 and schizophrenia. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274033     DOI: 10.1002/ajmg.b.30078

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  25 in total

1.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

Review 2.  Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder.

Authors:  Elena Ivleva; Gunvant Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2008-05-30       Impact factor: 9.306

3.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

4.  Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex.

Authors:  P J Ebert; D B Campbell; P Levitt
Journal:  Neuroscience       Date:  2006-09-25       Impact factor: 3.590

Review 5.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

6.  Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment.

Authors:  G Rivero; A M Gabilondo; J A García-Sevilla; L F Callado; R La Harpe; B Morentin; J J Meana
Journal:  Psychopharmacology (Berl)       Date:  2012-10-24       Impact factor: 4.530

7.  Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain.

Authors:  Hiroaki Okuda; Ryusuke Kuwahara; Shinsuke Matsuzaki; Shingo Miyata; Natsuko Kumamoto; Tsuyoshi Hattori; Shoko Shimizu; Kohei Yamada; Keisuke Kawamoto; Ryota Hashimoto; Masatoshi Takeda; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

8.  Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls.

Authors:  Richard Delorme; Catalina Betancur; Isabelle Scheid; Henrik Anckarsäter; Pauline Chaste; Stéphane Jamain; Franck Schuroff; Gudrun Nygren; Evelyn Herbrecht; Anne Dumaine; Marie Christine Mouren; Maria Råstam; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron
Journal:  BMC Med Genet       Date:  2010-07-05       Impact factor: 2.103

9.  RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample.

Authors:  Konasale M Prasad; Laura Almasy; Ruben C Gur; Raquel E Gur; Michael Pogue-Geile; Kodavali V Chowdari; Michael E Talkowski; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2009-03-12       Impact factor: 9.306

10.  Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals.

Authors:  Tilo Kircher; Axel Krug; Valentin Markov; Carin Whitney; Sören Krach; Klaus Zerres; Thomas Eggermann; Tony Stöcker; Nadim Jon Shah; Jens Treutlein; Markus M Nöthen; Tim Becker; Marcella Rietschel
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.